QIM
OREX

Quantitative Investment Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Quantitative Investment Management’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,550
Closed -$181K – 1053
2015
Q4 		$181K Sell
10,550
-5,270
-33% -$126K 0.01% 646
2015
Q3 		$333K Buy
15,820
+13,300
+528% +$456K 0.03% 524
2015
Q2 		$124K Buy
2,520
+170
+7% +$10.2K 0.02% 408
2015
Q1 		$184K Buy
+2,350
New +$146K 0.02% 575

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Quantitative Investment Management's OREX Position: Q1 2016 in Review

Quantitative Investment Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2016, closing a stake of 10,550 shares — an estimated $181K sold.

Quantitative Investment Management first reported a position in OREX in Q1 2015 and held it in 4 quarters. The position peaked at $333K in Q3 2015. 104 funds tracked by Wall St. Rank hold OREX as of Q1 2016.

  • Quantitative Investment Management reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • Quantitative Investment Management sold 10,550 Orexigen Therapeutics, Inc. shares in Q1 2016, an estimated $181K.
  • Quantitative Investment Management first reported a position in Orexigen Therapeutics, Inc. in Q1 2015 and held it in 4 quarters.
  • Quantitative Investment Management's Orexigen Therapeutics, Inc. position peaked at $333K in Q3 2015.
  • 104 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2016.

Based on Quantitative Investment Management's 13F filing for Q1 2016, filed 2 May 2016.